Screener
EBIT at other companies
Other financials
Where this comes from
Calculated from Oric Pharmaceuticals, Inc.’s reported figures.
The source filing: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026. Open the filing →
- Filed
- May 4, 2026, 4:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-204047
FAQ
- What is Oric Pharmaceuticals, Inc.'s EBIT?
- Oric Pharmaceuticals, Inc. (ORIC) reported EBIT of -$39.62M in Q1 2026.
- How has Oric Pharmaceuticals, Inc.'s EBIT changed year-over-year?
- Oric Pharmaceuticals, Inc.'s EBIT decreased by 21.1% year-over-year, from -$32.72M to -$39.62M.
- What is the long-term trend for Oric Pharmaceuticals, Inc.'s EBIT?
- Over 4 years (2021 to 2025), Oric Pharmaceuticals, Inc.'s EBIT has grown at a 16.0% compound annual growth rate (CAGR), from -$78.87M to -$143M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about Oric Pharmaceuticals, Inc.'s ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude